159 related articles for article (PubMed ID: 15168589)
21. Secondary malignancies after hematopoietic stem cell transplantation.
Ghelani D; Saliba R; Lima Md
Crit Rev Oncol Hematol; 2005 Oct; 56(1):115-26. PubMed ID: 15979325
[TBL] [Abstract][Full Text] [Related]
22. Second neoplasms following high-dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution.
Oddou S; Vey N; Viens P; Bardou VJ; Faucher C; Stoppa AM; Chabannon C; Camerlo J; Bouabdallah R; Gastaut JA; Maraninchi D; Blaise D
Leuk Lymphoma; 1998 Sep; 31(1-2):187-94. PubMed ID: 9720728
[TBL] [Abstract][Full Text] [Related]
23. Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation.
Socié G; Rizzo JD
Semin Hematol; 2012 Jan; 49(1):4-9. PubMed ID: 22221779
[TBL] [Abstract][Full Text] [Related]
24. Longterm followup and quality of life after hematopoietic stem cell transplantation.
Sullivan KM
J Rheumatol Suppl; 1997 May; 48():46-52. PubMed ID: 9150118
[TBL] [Abstract][Full Text] [Related]
25. Malignant neoplasms in long-term survivors of bone marrow transplantation. Late Effects Working Party of the European Cooperative Group for Blood and Marrow Transplantation and the European Late Effect Project Group.
Kolb HJ; Socié G; Duell T; Van Lint MT; Tichelli A; Apperley JF; Nekolla E; Ljungman P; Jacobsen N; van Weel M; Wick R; Weiss M; Prentice HG
Ann Intern Med; 1999 Nov; 131(10):738-44. PubMed ID: 10577296
[TBL] [Abstract][Full Text] [Related]
26. What do we need to know about allogeneic hematopoietic stem cell transplant survivors?
Clark CA; Savani M; Mohty M; Savani BN
Bone Marrow Transplant; 2016 Aug; 51(8):1025-31. PubMed ID: 27064688
[TBL] [Abstract][Full Text] [Related]
27. Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.
Battiwalla M; Tichelli A; Majhail NS
Biol Blood Marrow Transplant; 2017 Feb; 23(2):184-192. PubMed ID: 27818318
[TBL] [Abstract][Full Text] [Related]
28. Second neoplasms in adult patients submitted to haematopoietic stem cell transplantation.
Torrent A; Ferrá C; Morgades M; Jiménez MJ; Sancho JM; Vives S; Batlle M; Moreno M; Xicoy B; Oriol A; Ibarra G; Ribera JM
Med Clin (Barc); 2018 Jun; 150(11):421-427. PubMed ID: 28874263
[TBL] [Abstract][Full Text] [Related]
29. Subsequent malignancies after allogeneic hematopoietic stem cell transplantation.
Gündüz M; Özen M; Şahin U; Toprak SK; Civriz Bozdağ S; Kurt Yüksel M; Arslan Ö; Özcan M; Demirer T; Beksaç M; İlhan O; Gürman G; Topçuoğlu P
Clin Transplant; 2017 Jul; 31(7):. PubMed ID: 28432802
[TBL] [Abstract][Full Text] [Related]
30. Late effects in childhood cancer survivors and survivorship issues.
Haupt R; Jankovic M; Hjorth L; Skinner R
Epidemiol Prev; 2013; 37(1 Suppl 1):266-73. PubMed ID: 23585450
[No Abstract] [Full Text] [Related]
31. Old and new cancers after hematopoietic-cell transplantation.
Majhail NS
Hematology Am Soc Hematol Educ Program; 2008; ():142-9. PubMed ID: 19074072
[TBL] [Abstract][Full Text] [Related]
32. Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.
Seshadri T; Pintilie M; Kuruvilla J; Keating A; Tsang R; Zadeh S; Crump M
Leuk Lymphoma; 2009 Mar; 50(3):380-6. PubMed ID: 19347727
[TBL] [Abstract][Full Text] [Related]
33. Oral malignancies following HSCT: graft versus host disease and other risk factors.
Demarosi F; Lodi G; Carrassi A; Soligo D; Sardella A
Oral Oncol; 2005 Oct; 41(9):865-77. PubMed ID: 16084755
[TBL] [Abstract][Full Text] [Related]
34. Second solid cancers after allogeneic hematopoietic stem cell transplantation.
Gallagher G; Forrest DL
Cancer; 2007 Jan; 109(1):84-92. PubMed ID: 17131350
[TBL] [Abstract][Full Text] [Related]
35. Early-onset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation.
Fetscher S; Finke J; Engelhardt R; Mertelsmann R; Lange W
Ann Hematol; 1997 Feb; 74(2):73-7. PubMed ID: 9063376
[TBL] [Abstract][Full Text] [Related]
36. Donor-derived solid malignancies after hematopoietic stem cell transplantation.
Hu YX; Cui Q; Liang B; Huang H
Onkologie; 2010; 33(4):195-200. PubMed ID: 20389147
[TBL] [Abstract][Full Text] [Related]
37. Outcome and risk factors for late-onset complications 24 months beyond allogeneic hematopoietic stem cell transplantation.
Bieri S; Roosnek E; Ozsahin H; Huguet S; Ansari M; Trombetti A; Helg C; Chapuis B; Miralbell R; Passweg J; Chalandon Y
Eur J Haematol; 2011 Aug; 87(2):138-47. PubMed ID: 21535161
[TBL] [Abstract][Full Text] [Related]
38. Current Approach to Non-Infectious Pulmonary Complications of Hematopoietic Stem Cell Transplantation.
Cengiz Seval G; Topçuoğlu P; Demirer T
Balkan Med J; 2018 Mar; 35(2):131-140. PubMed ID: 29553463
[TBL] [Abstract][Full Text] [Related]
39. Metastatic gastric adenocarcinoma following allogeneic stem cell transplantation in a patient with acute myelogenous leukemia.
Tsimberidou AM; Medina J; Earl M; Sierra M; Shriki JE; Bueso-Ramos C; Giralt S; Beran M; Giles FJ; Garcia-Manero G
Bone Marrow Transplant; 2003 Mar; 31(5):413-4. PubMed ID: 12634736
[No Abstract] [Full Text] [Related]
40. Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).
Gabriel M; Shaw BE; Brazauskas R; Chen M; Margolis DA; Sengelov H; Dahlberg A; Ahmed IA; Delgado D; Lazarus HM; Gibson B; Myers KC; Kamble RT; Abdel-Mageed A; Li CK; Flowers MED; Battiwalla M; Savani BN; Majhail N; Shaw PJ
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1320-1326. PubMed ID: 28411175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
